131 related articles for article (PubMed ID: 29157673)
21. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the Distribution Profiles of Circulating MicroRNAs by Asymmetrical Flow Field Flow Fractionation.
Flack K; Jimenez LA; Zhong W
Methods Mol Biol; 2017; 1509():161-168. PubMed ID: 27826926
[TBL] [Abstract][Full Text] [Related]
23. Circulating microRNAs in human obesity: a systematic review.
Ortiz-Dosal A; Rodil-García P; Salazar-Olivo LA
Biomarkers; 2019 Sep; 24(6):499-509. PubMed ID: 30990364
[No Abstract] [Full Text] [Related]
24. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
[TBL] [Abstract][Full Text] [Related]
25. Novel circulating microRNAs expression profile in colon cancer: a pilot study.
Wang YN; Chen ZH; Chen WC
Eur J Med Res; 2017 Nov; 22(1):51. PubMed ID: 29187262
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.
Link A; Kupcinskas J
World J Gastroenterol; 2018 Aug; 24(30):3313-3329. PubMed ID: 30122873
[TBL] [Abstract][Full Text] [Related]
27. SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups.
Kleinschmidt-DeMasters BK; Donson AM; Richmond AM; Pekmezci M; Tihan T; Foreman NK
J Neuropathol Exp Neurol; 2016 Apr; 75(4):295-8. PubMed ID: 26945037
[TBL] [Abstract][Full Text] [Related]
28. Translating microRNAs into biomarkers: What is new for pediatric cancer?
de Carvalho IN; de Freitas RM; Vargas FR
Med Oncol; 2016 May; 33(5):49. PubMed ID: 27085875
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
30. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
31. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
Chen W; Li S
Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetics of pediatric central nervous system tumors.
Ullrich NJ; Pomeroy SL
Curr Oncol Rep; 2006 Nov; 8(6):423-9. PubMed ID: 17040620
[TBL] [Abstract][Full Text] [Related]
33. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
Prabhakar P; Chandra SR; Christopher R
Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors.
Kato Y; Hayatsu N; Kaneko MK; Ogasawara S; Hamano T; Takahashi S; Nishikawa R; Matsutani M; Mishima K; Narimatsu H
Biochem Biophys Res Commun; 2008 May; 369(4):1041-6. PubMed ID: 18329383
[TBL] [Abstract][Full Text] [Related]
35. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
Cui X; You L; Zhu L; Wang X; Zhou Y; Li Y; Wen J; Xia Y; Wang X; Ji C; Guo X
Metabolism; 2018 Jan; 78():95-105. PubMed ID: 28966078
[TBL] [Abstract][Full Text] [Related]
36. Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors.
Pezuk JA; Salomão KB; Baroni M; Pereira CA; Geron L; Brassesco MS
Cancer Metastasis Rev; 2019 Dec; 38(4):813-828. PubMed ID: 31797180
[TBL] [Abstract][Full Text] [Related]
37. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA
BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036
[TBL] [Abstract][Full Text] [Related]
40. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.
Bell E; Watson HL; Bailey S; Murray MJ; Coleman N
Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
